February 12, 2013
Program Description
Join FDLI for our upcoming program—Pharmacy Compounding: An FDLI Dialogue—on February 12 in Washington, DC. In an open, balanced format, experts will discuss and debate the regulation of pharmacy compounding, providing a historical framework and exploring recent developments. Participants will delve into key questions about policy, surveillance and enforcement, legislative and oversight issues. Discussion will address unresolved questions related to defining "compounding" and "manufacturing", as well as how the courts and Congress have interpreted FDA’s authority and role in regulating pharmacy compounding. With newly proposed legislation, the courts split, and statutory authority at issue, this is the ideal time for stakeholders to convene, communicate, and look ahead to what is next.More information can be found here
No comments:
Post a Comment